Cost of Illness < Cost-Benefit Analysis < Costs and Cost Analysis

Facettes : Author.f Mesh.f AffPays.f

List of bibliographic references

Number of relevant bibliographic references: 29.
[0-20] [0 - 20][0 - 29][20-28][20-40]

Ident.	Authors (with country if any)	Title
000135 (1995)	S. Bertozzi	Assessing and alleviating the real impact of AIDS.
000265 (2005)	Motasim Badri ; Gary Maartens ; Sundhiya Mandalia ; Linda-Gail Bekker ; John R. Penrod ; Robert W. Platt ; Robin Wood ; Eduard J. Beck	Cost-Effectiveness of Highly Active Antiretroviral Therapy in South Africa
000971 (2010)	Lawrence Long [Afrique du Sud] ; Matthew Fox ; Ian Sanne ; Sydney Rosen	The high cost of second-line antiretroviral therapy for HIV/AIDS in South Africa.
000C92 (2010)	Eugene Athan [Australie] ; Daniel P. O'Brien ; Rosa Legood	Cost-effectiveness of routine and low-cost CD4 T-cell count compared with WHO clinical staging of HIV to guide initiation of antiretroviral therapy in resource-limited settings.
000E92 (2010)	John M. Kaldor [Australie] ; David P. Wilson	How low can you go: the impact of a modestly effective HIV vaccine compared with male circumcision.
001008 (2010)	Elioda Tumwesigye [Ouganda] ; Goodwill Wana ; Simon Kasasa ; Elly Muganzi ; Fred Nuwaha	High uptake of home-based, district-wide, HIV counseling and testing in Uganda.
001034 (2010)	Denise Lawrie ; George Janossy ; Maarten Roos ; Deborah K. Glencross	Comprehensive & cost effective laboratory monitoring of HIV/AIDS: an African role model.
001791 (2013)	Noreen Dadirai Mdege [Royaume-Uni] ; Stanley Chindove ; Shehzad Ali	The effectiveness and cost implications of task-shifting in the delivery of antiretroviral therapy to HIV-infected patients: a systematic review.
001955 (2013)	Gesine Meyer-Rath [États-Unis] ; Alana Brennan ; Lawrence Long ; Buyiswa Ndibongo ; Karl Technau ; Harry Moultrie ; Lee Fairlie ; Ashraf Coovadia ; Sydney Rosen	Cost and outcomes of paediatric antiretroviral treatment in South Africa.
001A03 (2013)	Julie H. Levison [États-Unis] ; Robin Wood ; Callie A. Scott ; Andrea L. Ciaranello ; Neil A. Martinson ; Corina Rusu ; Elena Losina ; Kenneth A. Freedberg ; Rochelle P. Walensky	The clinical and economic impact of genotype testing at first-line antiretroviral therapy failure for HIV-infected patients in South Africa.
001B62 (2013)	Ide Cremin [Royaume-Uni] ; Ramzi Alsallaq ; Mark Dybul ; Peter Piot ; Geoffrey Garnett ; Timothy B. Hallett	The new role of antiretrovirals in combination HIV prevention: a mathematical modelling analysis.
001C94 (2013)	Avinash K. Shetty [États-Unis]	Epidemiology of HIV infection in women and children: a global perspective.
001D26 (2013)	Karen Schneider [Australie] ; Chidi Nwizu ; Richard Kaplan ; Jonathan Anderson ; David P. Wilson ; Sean Emery ; David A. Cooper ; Mark A. Boyd	The potential cost and benefits of raltegravir in simplified second-line therapy among HIV infected patients in Nigeria and South Africa.
001D35 (2013)	Janne Estill [Suisse] ; Matthias Egger ; Nello Blaser ; Luisa Salazar Vizcaya ; Daniela Garone ; Robin Wood ; Jennifer Campbell ; Timothy B. Hallett ; Olivia Keiser	Cost-effectiveness of point-of-care viral load monitoring of antiretroviral therapy in resource-limited settings: mathematical modelling study.
001D49 (2013)	Garry R. Barton [Royaume-Uni] ; Lara Fairall ; Max O. Bachmann ; Kerry Uebel ; Venessa Timmerman ; Carl Lombard ; Merrick Zwarenstein	Cost-effectiveness of nurse-led versus doctor-led antiretroviral treatment in South Africa: pragmatic cluster randomised trial.
001F11 (2013)	Sebastian Kevany [États-Unis] ; Solomon R. Benatar ; Theodore Fleischer	Improving resource allocation decisions for health and HIV programmes in South Africa: Bioethical, cost-effectiveness and health diplomacy considerations.
002060 (2013)	Rochelle P. Walensky [États-Unis]	Combination HIV prevention: the value and interpretation of mathematical models.
002126 (2013)	Kazeem O. Okosun [Afrique du Sud] ; Oluwole D. Makinde ; Isaac Takaidza	Analysis of recruitment and industrial human resources management for optimal productivity in the presence of the HIV/AIDS epidemic.
002166 (2013)	Joseph N. Jarvis [Royaume-Uni] ; Thomas S. Harrison ; Stephen D. Lawn ; Graeme Meintjes ; Robin Wood ; Susan Cleary	Cost effectiveness of cryptococcal antigen screening as a strategy to prevent HIV-associated cryptococcal meningitis in South Africa.
002263 (2013)	L. Renner [Ghana] ; F A Nkansah ; A N O. Dodoo	The role of generic medicines and biosimilars in oncology in low-income countries.
002400 (2013)	Thu-Ha Dinh [Afrique du Sud] ; Mary L. Kamb ; Veerle Msimang ; Muptal Likibi ; Thabo Molebatsi ; Thurma Goldman ; David A. Lewis	Integration of preventing mother-to-child transmission of HIV and syphilis testing and treatment in antenatal care services in the Northern Cape and Gauteng provinces, South Africa.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/Ncbi/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i -k "Cost-Benefit Analysis" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i  \
                -Sk "Cost-Benefit Analysis" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaSubSaharaV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Cost-Benefit Analysis
}}

---

This area was generated with Dilib version V0.6.32. Data generation: Mon Nov 13 19:31:10 2017. Site generation: Wed Mar 6 19:14:32 2024